Annual Gross Margin
N/A
December 1, 2023
Summary
- CATX annual gross profit margin is not available.
Performance
CATX Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Gross Margin
N/A
September 1, 2024
Summary
- CATX quarterly gross profit margin is not available.
Performance
CATX Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
CATX Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CATX Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Perspective Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 23.00%(-46.2%) | - |
| Sep 2022 | - | 24.11%(-34.8%) |
| Jun 2022 | - | 36.97%(-25.3%) |
| Jun 2022 | 42.76%(-16.1%) | - |
| Mar 2022 | - | 49.52%(+14.3%) |
| Dec 2021 | - | 43.32%(+7.9%) |
| Sep 2021 | - | 40.13%(-19.2%) |
| Jun 2021 | 50.94%(-3.8%) | - |
| Jun 2021 | - | 49.67%(-5.2%) |
| Mar 2021 | - | 52.38%(+5.9%) |
| Dec 2020 | - | 49.47%(-5.4%) |
| Sep 2020 | - | 52.27%(+11.2%) |
| Jun 2020 | 52.93%(+27.1%) | 46.99%(-20.7%) |
| Mar 2020 | - | 59.24%(+17.6%) |
| Dec 2019 | - | 50.36%(-5.7%) |
| Sep 2019 | - | 53.39%(+16.9%) |
| Jun 2019 | 41.66%(+34.0%) | 45.69%(0.0%) |
| Mar 2019 | - | 45.69%(+13.7%) |
| Dec 2018 | - | 40.18%(+19.8%) |
| Sep 2018 | - | 33.55%(+23.1%) |
| Jun 2018 | 31.10%(+76.7%) | 27.26%(-29.6%) |
| Mar 2018 | - | 38.72%(+12.0%) |
| Dec 2017 | - | 34.57%(+58.0%) |
| Sep 2017 | - | 21.88%(-39.8%) |
| Jun 2017 | 17.60%(+549.4%) | 36.35%(+59.1%) |
| Mar 2017 | - | 22.85%(<-9900.0%) |
| Dec 2016 | - | -0.10%(-102.3%) |
| Sep 2016 | - | 4.44%(-203.5%) |
| Jun 2016 | 2.71%(-25.3%) | -4.29%(-176.7%) |
| Mar 2016 | - | 5.59%(+146.3%) |
| Dec 2015 | - | 2.27%(-65.5%) |
| Sep 2015 | - | 6.58%(-56.9%) |
| Jun 2015 | 3.63%(-177.9%) | 15.26%(+219.9%) |
| Mar 2015 | - | 4.77%(-234.0%) |
| Dec 2014 | - | -3.56%(-32.3%) |
| Sep 2014 | - | -5.26%(-63.3%) |
| Jun 2014 | -4.66% | -14.34%(-419.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | 4.49%(-243.9%) |
| Dec 2013 | - | -3.12%(-57.6%) |
| Sep 2013 | - | -7.36%(-163.8%) |
| Jun 2013 | 3.32%(-76.1%) | 11.54%(-22.3%) |
| Mar 2013 | - | 14.85%(-191.3%) |
| Dec 2012 | - | -16.26%(+742.5%) |
| Sep 2012 | - | -1.93%(-110.8%) |
| Jun 2012 | 13.87%(-37.2%) | 17.82%(+15.0%) |
| Mar 2012 | - | 15.50%(-4.3%) |
| Dec 2011 | - | 16.19%(+196.0%) |
| Sep 2011 | - | 5.47%(-84.9%) |
| Jun 2011 | 22.09%(+60.9%) | 36.34%(+43.4%) |
| Mar 2011 | - | 25.34%(+146.5%) |
| Dec 2010 | - | 10.28%(-36.7%) |
| Sep 2010 | - | 16.25%(+16.6%) |
| Jun 2010 | 13.73%(-310.6%) | 13.94%(+219.7%) |
| Mar 2010 | - | 4.36%(-77.8%) |
| Dec 2009 | - | 19.60%(+23.4%) |
| Sep 2009 | - | 15.88%(-553.7%) |
| Jun 2009 | -6.52%(+207.5%) | -3.50%(-412.5%) |
| Mar 2009 | - | 1.12%(-103.7%) |
| Dec 2008 | - | -29.96%(-740.2%) |
| Sep 2008 | - | 4.68%(-78.4%) |
| Jun 2008 | -2.12%(+123.2%) | 21.64%(+283.7%) |
| Mar 2008 | - | 5.64%(-120.5%) |
| Dec 2007 | - | -27.49%(+240.6%) |
| Sep 2007 | - | -8.07%(+1693.3%) |
| Jun 2007 | -0.95%(-99.0%) | -0.45%(-103.9%) |
| Mar 2007 | - | 11.47%(+506.9%) |
| Dec 2006 | - | 1.89%(-107.4%) |
| Sep 2006 | - | -25.62%(-63.2%) |
| Jun 2006 | -91.30%(-1048.1%) | -69.60%(+6.8%) |
| Mar 2006 | - | -65.15%(-26.3%) |
| Dec 2005 | - | -88.44%(-63.4%) |
| Sep 2005 | - | -241.45% |
| Sep 1996 | 9.63%(-8.5%) | - |
| Sep 1995 | 10.52%(+94.1%) | - |
| Sep 1994 | 5.42% | - |
FAQ
- What is the all time high annual gross margin for Perspective Therapeutics?
- What is the all time high quarterly gross margin for Perspective Therapeutics?
What is the all time high annual gross margin for Perspective Therapeutics?
Perspective Therapeutics all-time high annual gross profit margin is 52.93%
What is the all time high quarterly gross margin for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly gross profit margin is 59.24%